Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
ALDH5A1 7915 CHLORMERODRIN CHEMBL2110562 inhibitor DrugBank 11752352, 17139284, 17016423, 5692397
ALDH5A1 7915 VALPROATE SODIUM CHEMBL433 inhibitor ChemblInteractions
ALDH5A1 7915 VALPROIC ACID CHEMBL109 inhibitor ChemblInteractions
ALDH5A1 7915 SUCCINIC ACID CHEMBL576 inhibitor DrugBank, TTD 15853764, 11752352, 16942602, 17619587, 17584458, 16689938
ALDH5A1 7915 CHEMBL1161866 CHEMBL1161866 DrugBank 17139284, 17016423
ALDH5A1 7915 DIVALPROEX SODIUM CHEMBL2105613 inhibitor ChemblInteractions
ALDH5A1 7915 CHEMBL378577 CHEMBL378577 inhibitor GuideToPharmacologyInteractions

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
ALDH5A1 rs2760118 CT + TT methadone efficacy yes Patients carrying the T allele were at a higher risk of being a non-responder to methadone treatment as compared to those with the CC genotype. Responders defined as those who had negative results for illicit opioids in all of the last four urine tests. Nonresponders were those with two or more positive results in the last four urine tests. Responders also had a significantly higher mean methadone dose (p=0.001) and a mean number of months in the methadone maintenance treatment (MMT) program (p=0.009). However, when controlling for these two variables, the association between genotype and response remained statistically significant (p=0.0049). Genotypes CT + TT is associated with decreased response to methadone in people with Opioid-Related Disorders as compared to genotype CC. 24230997 1444698532